(Q46471157)

English

A prospective clinical trial of green tea for hormone refractory prostate cancer: an evaluation of the complementary/alternative therapy approach

scientific article published in March 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15869995

A prospective clinical trial of green tea for hormone refractory prostate cancer: an evaluation of the complementary/alternative therapy approach (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15869995

0 references

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

E Choan

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15869995

Roanne Segal

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15869995

Derek Jonker

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15869995

Shawn Malone

4

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15869995

Neil Reaume

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15869995

Libni Eapen

6

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15869995

Victor Gallant

7

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15869995

publication date

1 March 2005

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15869995

Urologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15869995

23

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15869995

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15869995

108-113

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15869995

Complementary and alternative medicine in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.008

7 January 2021

Prevention of photocarcinogenesis by topical administration of pure epigallocatechin gallate isolated from green tea

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.008

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.008

7 January 2021

Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallate

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.008

7 January 2021

Induction of apoptosis in prostate cancer cell lines by the green tea component, (-)-epigallocatechin-3-gallate

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.008

7 January 2021

Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.008

7 January 2021

Molecular targets for green tea in prostate cancer prevention

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.008

7 January 2021

Phase I trial of oral green tea extract in adult patients with solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.008

7 January 2021

A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.008

7 January 2021

Evaluation of tumor progression by repeated fine needle biopsies in prostate adenocarcinoma: modal deoxyribonucleic acid value and cytological differentiation

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.008

7 January 2021

Identifiers

10.1016/J.UROLONC.2004.10.008

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15869995

release_ay5qaqjxxzcurgwsm5mboprv4m

1 reference

https://api.fatcat.wiki/v0/release/ay5qaqjxxzcurgwsm5mboprv4m

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15869995

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46471157&oldid=2113183186"